top of page
KOHIVI - HIV Persistence & Immune Response
This study follows individuals living with HIV over an extended period to analyze the dynamic relationship between HIV persistence—how the virus remains in the body despite treatment—and the immune system’s specific responses to the virus.
SAMBA - Novel Hepatitis B Therapy
This first-in-human Phase 1 study tests the safety and antiviral effects of HepB mAb19, a new antibody treatment targeting the hepatitis B virus. It involves people with chronic hepatitis B already on standard antiviral therapy
RIO - Broadly Neutralizing Antibodies as HIV Therapy
The RIO study is a Phase II trial conducted at multiple centers around the world. It tests HIV-specific broadly neutralizing antibodies (bNAbs) to evaluate their safety and effectiveness across several groups.
bottom of page